)
MapLight Therapeutics (MPLT) investor relations material
MapLight Therapeutics IPO Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Clinical-stage biopharmaceutical company focused on CNS disorders, leveraging a proprietary platform to identify and modulate disease-relevant neural circuits.
Lead candidate ML-007C-MA targets schizophrenia and Alzheimer's disease psychosis (ADP) via M₁/M4 muscarinic agonism, with a precision-matched peripheral antagonist to improve tolerability.
Pipeline includes ML-004 for autism spectrum disorder (ASD), ML-021 for Parkinson’s disease, and ML-009 for hyperactivity/impulsivity disorders, with all programs retaining global rights.
Management team and founders have deep neuroscience and drug development expertise, supported by leading investors and scientific advisors.
Financial performance and metrics
Net losses: $77.6M (2024), $55.7M (2023), $52.2M (H1 2025); accumulated deficit of $251.6M as of June 30, 2025.
Operating expenses: $82.9M (2024), $57.2M (2023), $54.2M (H1 2025), driven by R&D and increased headcount.
Cash, cash equivalents, and short-term investments: $60.5M as of June 30, 2025; $200M raised in Series D preferred stock in July/Sept 2025.
Pro forma net tangible book value post-offering: $12.01/share; immediate dilution to new investors: $4.99/share.
Use of proceeds and capital allocation
Net proceeds from IPO and concurrent private placement estimated at $234.8M.
Planned allocation: $100–120M for ML-007C-MA in schizophrenia (Phase 2), $50–70M for ML-007C-MA in ADP (Phase 2), $15–25M for ML-004 in ASD (Phase 2), $30–40M for preclinical R&D, remainder for working capital and general purposes.
Proceeds expected to fund operations through 2027; additional capital will be needed for regulatory approval and commercialization.
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)